The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal patients: factors influencing the success of patient recruitment.

Source:http://linkedlifedata.com/resource/pubmed/id/12376201

Download in:

View as

General Info

PMID
12376201